High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

Clinical trial NCT02551718 · COMPLETED

Trial details

NCT number: NCT02551718
Sponsor: University of Washington
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Recurrent Acute Leukemia of Ambiguous Lineage Recurrent Acute Lymphoblastic Leukemia Recurrent Acute Myeloid Leukemia Refractory Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia Refractory Acute Leukemia of Ambiguous Lineage

Start date: 2015-09-11
Primary completion: 2020-06-19
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.